Carcinoma in situ of skin of right upper eyelid, including canthus
ICD-10 D04.111 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of right upper eyelid, including canthus.
Carcinoma in situ (CIS) of the skin is a non-invasive form of cancer that is confined to the epidermis, the outermost layer of skin. In the case of D04.111, the carcinoma is specifically located on the right upper eyelid, including the canthus, which is the corner of the eye where the upper and lower eyelids meet. This condition is characterized by abnormal growth of skin cells that have not yet invaded deeper tissues. While CIS is not life-threatening, it has the potential to progress to invasive cancer if left untreated. Regular surveillance and monitoring are crucial, especially for patients with a history of skin cancers or significant sun exposure. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy, depending on the size and characteristics of the lesion. The prognosis is generally favorable with appropriate management, but vigilance is necessary to prevent recurrence or progression.
Detailed clinical notes describing the lesion, treatment plan, and follow-up care.
Diagnosis and treatment of skin lesions, including biopsies and excisions.
Ensure accurate documentation of the lesion's characteristics and location to avoid misclassification.
Comprehensive eye examination notes, including visual acuity and any ocular symptoms.
Management of eyelid lesions, including surgical interventions and cosmetic considerations.
Document any impact on vision or eyelid function due to the carcinoma.
Used when excising a carcinoma in situ from the eyelid.
Pathology report confirming carcinoma in situ and operative notes detailing the excision.
Dermatology and ophthalmology must coordinate on the excision approach.
Carcinoma in situ is a non-invasive cancer that has not spread beyond the epidermis. It is crucial to identify and treat it early to prevent progression to invasive cancer.
